NRS
OGN icon

Neville Rodie & Shaw’s Organon & Co OGN Stock Holding History

Neville Rodie & Shaw’s Portfolio OGN Stock Details OGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-8,177
Closed -$268K – 266
2021
Q3 		$268K Sell
8,177
-14,561
-64% -$466K 0.02% 229
2021
Q2 		$688K Buy
+22,738
New +$748K 0.05% 156

Other funds holding OGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Neville Rodie & Shaw's OGN Position: Q4 2021 in Review

Neville Rodie & Shaw sold out of Organon & Co (OGN) in Q4 2021, closing a stake of 8,177 shares — an estimated $268K sold.

Neville Rodie & Shaw first reported a position in OGN in Q2 2021 and held it in 2 quarters. The position peaked at $688K in Q2 2021. 908 funds tracked by Wall St. Rank hold OGN as of Q4 2021.

  • Neville Rodie & Shaw reported no remaining Organon & Co position as of Q4 2021 after selling out during the quarter.
  • Neville Rodie & Shaw sold 8,177 Organon & Co shares in Q4 2021, an estimated $268K.
  • Neville Rodie & Shaw first reported a position in Organon & Co in Q2 2021 and held it in 2 quarters.
  • Neville Rodie & Shaw's Organon & Co position peaked at $688K in Q2 2021.
  • 908 funds tracked by Wall St. Rank held Organon & Co as of Q4 2021.

Based on Neville Rodie & Shaw's 13F filing for Q4 2021, filed 5 Jan 2022.